Moreover, there is a substantial lack of longitudinal studies assessing vaspin concentrations in patients undergoing treatment; notably, no such studies have been conducted in individuals with T2DM [69,73,85,86,117,120]. Here, SERPINA12 is linked to type 2 diabetes mellitus.